Harness the hydrating power of hyaluronic acid3 for your face, décolletage and hands.4
A hydrated† glow§ that lasts all day, every day for up to 9 months1,2
Meet your unique beauty goals with hyaluronic acid for the face – after just one SKINVIVE™ treatment, people were happy with their skin for up to 9 months.2,††,‡‡
These quotations are the opinion of individual patients and not scripted by Allergan Aesthetics, an AbbVie company.
Find your nearest clinic
For a deep,* long-lasting¶
injectable skin hydration treatment that
helps you meet your unique beauty
goals,1,4 speak to a practitioner about
SKINVIVE™.
SKINVIVE™ by JUVÉDERM® is an injectable implant used for the treatment, by filling, of superficial cutaneous depressions such as fine lines and for additional improvement of skin quality attributes such as hydration and elasticity.4
Footnotes
- *Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively).1
- †Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) and top-up treatment administered at Day 30 (n=31).1
- ‡Lasting up to 9 months as reported by 55.1% of patients. As reported by 127 of 131 patients in a composite satisfaction score, which includes how smooth their facial skin looked.2
- §Lasting up to 9 months as reported by 63% of patients. As reported by 127 of 131 patients in a composite satisfaction score, which includes how radiant their facial skin looked.2
- ‖Lasting up to 9 months as reported by 76.2% of patients. As reported by 127 of 131 patients (1 subject did not respond) in a composite satisfaction score, which includes how healthy their facial skin looked.2
- ¶Long-lasting is up to 9 months following a single treatment.1
- **Lasting up to 9 months as reported by 67.7% of patients. As reported by 127 of 131 patients (3 subjects did not respond) in a composite satisfaction score, which includes satisfaction with their skin’s tone (colour).2
- ††Subjects completed the FACE-Q Satisfaction With Skin scale at baseline (Day 0, before treatment), Months 1, 4, 6, and 9 (before repeat treatment, if received), and Month 1 after the repeat treatment (n=131; n=62 received repeat treatment). The Satisfaction With Skin scale is a validated patient-reported outcome instrument designed to assess the impact of treatment from the subject's perspective. The scale comprises 12 questions about satisfaction with different facial skin attributes (e.g. smoothness, clearness, radiance). Responses are rated on a 4-point scale (1: very dissatisfied, 4: very satisfied). Scores for each item were summed and converted to a scale score (range: 0-100; higher scores indicate greater satisfaction) using the algorithm developed by the FACE-Q developers.2
- ‡‡Defined as having improved satisfaction from baseline on the FACE-Q Satisfaction With Skin scale, as reported by 127 of 131 patients at Month 9.2
References
- Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791-798.
- Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065-1070.
- Nakab L et al. Plast Reconstr Surg Glob Open. 2020;8(3):e2723.
- Juvédum® VOLITE DFU. 73655JR10. Revision 2019-09-09.
[Local markets to update reference 4 to locally available SKINVIVE™ DFU]
Models treated with SKINVIVE™. Individual results may vary.
Website produced and funded by Allergan Aesthetics, an AbbVie company.
Directions for consumers
This content is intended for [insert country name] adult (>18yrs) audience only. You should always consult a healthcare professional to help you decide if SKINVIVE™ by JUVÉDERM® is right for you and provide you with a full list of side effects.
Directions for healthcare professionals
Patients may experience potential side effects with SKINVIVE™ by JUVÉDERM® facial filter, which include inflammatory reactions (redness, oedema, erythema, etc.), haematomas, induration or nodules, staining or discolourations at injection site, etc. Please refer to SKINVIVE™ by JUVÉDERM® Directions for Use (DFU) for a full list of adverse events.4
Adverse events should be reported. Reporting forms and information can be found at [insert local reporting information details]. Adverse events should also be reported to Allergan Aesthetics [insert local contact details for AE reporting].